Medicare Enrolled

Dr. Jeffrey Margolis, M.D.

Hematology & Oncology · Madison Heights, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
27301 DEQUINDRE RD, Madison Heights, MI 48071
2483994400
In practice since 2005 (20 years)
NPI: 1871577544 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Margolis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Margolis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Margolis

Dr. Jeffrey Margolis is a hematology & oncology specialist in Madison Heights, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Margolis performed 221,842 Medicare services across 4,825 unique beneficiaries.

Between the years covered by Open Payments, Dr. Margolis received a total of $2,014 from 24 pharmaceutical and/or device companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Margolis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in MI $2,014 industry payments

Medicare Practice Summary

Medicare Utilization ↗
221,842
Medicare services
Top 1% in MI for hematology & oncology
4,825
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11,092 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Filgrastim injection (Nivestym) for white blood cells
An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram.
46,020 $0 $1
Pembrolizumab injection (Keytruda) 29,600 $43 $165
Anti-nausea injection (fosaprepitant)
An injection of fosaprepitant, a medication used to prevent nausea and vomiting.
28,500 $0 $1
Oxaliplatin chemotherapy injection
This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg.
24,100 $0 $1
Denosumab injection (Prolia/Xgeva) 18,120 $18 $72
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
17,340 $0 $2
Epoetin alfa injection (Retacrit) for anemia
An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units.
12,000 $6 $24
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
6,664 $36 $138
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
5,398 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 3,200 $1 $4
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
3,174 $8 $23
Rituximab-pvvr biosimilar injection, 10 mg
An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose.
3,060 $23 $91
Basic blood chemical test (calcium, ionized)
A blood test that measures basic chemical levels, specifically including calcium and ionized calcium.
2,872 $13 $41
Pemetrexed injection, 10 mg
Administration of a 10 mg dose of pemetrexed medication via injection.
2,380 $13 $52
Injection, octreotide, depot form for intramuscular injection, 1 mg 1,930 $161 $619
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,625 $70 $265
Injection, leucovorin calcium, per 50 mg 1,620 $3 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,449 $100 $376
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
1,186 $23 $96
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
1,095 $2 $8
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
876 $104 $443
Anti-nausea injection (ondansetron/Zofran) 872 $0 $1
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
831 $11 $42
Injection, granisetron hydrochloride, 100 mcg 690 $0 $2
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
610 $6 $27
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 601 $3 $11
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
550 $12 $51
Pegfilgrastim-jmdb injection
An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg.
468 $91 $353
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
374 $2 $8
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
372 $1 $3
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
336 $49 $221
Pegfilgrastim injection, 0.5 mg
An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions.
336 $96 $367
Cyclophosphamide, 100 mg 304 $15 $62
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
290 $51 $214
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
258 $1 $4
Injection, potassium chloride, per 2 meq 250 $0 $1
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
232 $23 $94
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
184 $16 $66
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
174 $1 $5
Leuprolide acetate (for depot suspension), 7.5 mg 166 $130 $520
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
159 $1 $6
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
114 $30 $123
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
114 $2 $8
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
111 $27 $98
IV chemotherapy initiation with community continuation
Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living.
111 $126 $470
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
92 $26 $107
Concurrent intravenous infusion
Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given.
92 $16 $63
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
90 $58 $247
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
86 $42 $166
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
85 $43 $185
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
84 $3 $13
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
77 $10 $42
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
71 $63 $205
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
67 $43 $166
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
64 $144 $528
New patient office visit, complex (60-74 min) 45 $174 $648
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
44 $134 $491
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
39 $72 $213
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
39 $7 $7
Total bilirubin level test
A blood test that measures the total amount of bilirubin, a waste product from the breakdown of red blood cells, in your body.
32 $5 $30
On-body injector for subcutaneous injection
A device is applied to the skin to automatically deliver a medication injection under the skin.
28 $15 $59
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
21 $41 $113
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
20 $6 $6
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
20 $19 $87
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
19 $106 $392
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
11 $5 $15
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.2% high complexity
83.1% medium
4.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,014
Total received (2018-2024)
Avg $288/year across 7 years
Top 44% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
38
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,734 (86.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$281 (13.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$315
2023
$72
2022
$87
2021
$173
2020
$351
2019
$564
2018
$452

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HISTOSONICS,INC.
$146
Ipsen Biopharmaceuticals, Inc
$132
Blue Earth Diagnostics Limited
$19
Daiichi Sankyo Inc.
$17
Top 3 companies account for 94.5% of 2024 payments
All-time payments by company (2018-2024) ›
ASD SPECIALTY HEALTHCARE, LLC
$270
ASD Specialty Healthcare, LLC
$223
Amgen Inc.
$221
Lilly USA, LLC
$154
HISTOSONICS,INC.
$146
Janssen Biotech, Inc.
$135
Ipsen Biopharmaceuticals, Inc
$132
Janssen Pharmaceuticals, Inc
$129
AstraZeneca Pharmaceuticals LP
$125
Incyte Corporation
$100
E.R. Squibb & Sons, L.L.C.
$75
Astellas Pharma US Inc
$46
Bayer Healthcare Pharmaceuticals Inc.
$41
Genentech USA, Inc.
$40
Verity Pharmaceuticals Inc.
$31
Celgene Corporation
$29
Grifols USA, LLC
$19
Blue Earth Diagnostics Limited
$19
Daiichi Sankyo Inc.
$17
Helsinn Therapeutics (U.S.), Inc.
$15
Sun Pharmaceutical Industries Inc.
$13
PFIZER INC.
$13
Gilead Sciences, Inc.
$12
Sysmex Inostics Inc
$8
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
AKYNZEO · BALVERSA · BRAFTOVI · CYRAMZA · DARZALEX · Gamunex-C · Herceptin · IMFINZI · INVOKANA · JAKAFI · Nubeqa · OPDIVO · Onivyde · POSLUMA · Perjeta · Pomalyst · Prolia · Trelstar · Vanflyta · Vectibix · XARELTO · Xospata · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Madison Heights?
Compare hematology & oncology specialists in the Madison Heights area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
121
Per 100K population
9.5
County median income
$95,296
Nearest hospital
THE BEHAVIORAL CENTER OF MICHIGAN
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Margolis is a mixed practice specialist, with above-average Medicare volume (top 1% in MI), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Margolis experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Margolis performed 46,020 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Margolis receive payments from pharmaceutical companies?
Yes. Dr. Margolis received a total of $2,014 from 24 companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Margolis's costs compare to other hematology & oncology specialists in Madison Heights?
Dr. Margolis's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Margolis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →